U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07368959) titled 'AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction' on Jan. 23.
Brief Summary: The purpose of this study is to assess the efficacy and safety of single injection dose of AURN001 compared with placebo in adult participants with corneal edema secondary to corneal endothelial dysfunction.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Corneal Edema
Corneal Endothelial Dysfunction
Fuchs Endothelial Corneal Dysfunction
Pseudophakic Bullous Keratopathy (PBK)
Intervention:
DRUG: Combination Product: AURN001 + Y-27632
AURN001 will be injected to the anterior chamber of ...